Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Be sure to check out our other blog: Hepatitis & Tattoos
Wednesday, May 16, 2012
Ribavirin Helps Early Hepatitis C Treatment in People with HIV
If detected and treated during the acute or early stages of HCV infection, overall sustained response rates are very high with pegylated interferon alone. But HIV positive people typically do not respond as well to interferon and may need more intensive treatment for acute hepatitis C. Ribavirin is known to reduce the risk of post-treatment relapse and therefore raise the odds of a cure.